Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Braz. j. med. biol. res ; 54(12): e11610, 2021. tab, graf
Article in English | LILACS-Express | LILACS | ID: biblio-1345566

ABSTRACT

Due to the high transfusion volume, polytransfused patients with sickle cell disease (SCD) and beta-thalassemia are constantly exposed to parenterally transmitted infections. Currently, we have little information about the virome of such patients and how the virological composition might be influenced by the hemotherapy procedures that these patients receive. The objective of this study was to compare the viral diversity between these two groups with respect to the viral abundance and how it might be affected by the specific conditions of these groups. We sequenced by next-generation sequencing (NGS) and compared the virome of 30 patients with beta-thalassemia major, 45 with SCD, and 16 blood donors from the Blood Center of Ribeirão Preto, Brazil. Predominantly, commensal viruses including Torque teno virus (TTV) genotypes and human pegiviris-1 (HPgV-1) were identified in each group. Strikingly, while HPgV-1 reads were dominant in the SCD group, thalassemic patients showed high TTV abundance, expressed both in viral reads and genotypes. We speculated that the commensal virome of polytransfused patients might be influenced by the transfusion frequency and disease characteristics and that commensal viruses might be used as important genetic biomarkers for these hematological disturbances. Nevertheless, more specific studies are necessary to confirm a relationship between blood virome and transfusion treatment.

2.
Braz. j. med. biol. res ; 49(5): e5420, 2016. graf
Article in English | LILACS | ID: biblio-951672

ABSTRACT

Zika virus (ZIKV), a mosquito-borne flavivirus, belongs to the Flaviviridae family, genus Flavivirus. ZIKV was initially isolated in 1947 from a sentinel monkey in the Zika forest, Uganda. Little clinical importance was attributed to ZIKV, once only few symptomatic cases were reported in some African and Southeast Asiatic countries. This situation changed in 2007, when a large outbreak was registered on the Yap Island, Micronesia, caused by the Asian ZIKV lineage. Between 2013 and 2014, ZIKV spread explosively and caused many outbreaks in different islands of the Southern Pacific Ocean and in 2015 autochthonous transmission was reported in Brazil. Currently, Brazil is the country with the highest number of ZIKV-positive cases in Latin America. Moreover, for the first time after the discovery of ZIKV, the Brazilian scientists are studying the possibility for the virus to cause severe congenital infection related to microcephaly and serious birth defects due to the time-spatial coincidence of the alarming increase of newborns with microcephaly and the Brazilian ZIKV epidemic. The present review summarizes recent information for ZIKV epidemiology, clinical picture, transmission, diagnosis and the consequences of this emerging virus in Brazil.


Subject(s)
Humans , Animals , Infant, Newborn , Epidemics , Zika Virus/genetics , Zika Virus Infection/embryology , Zika Virus Infection/transmission , Zika Virus Infection/virology , Brazil/epidemiology , Microcephaly/epidemiology , Microcephaly/virology
3.
Braz. j. med. biol. res ; 48(9): 777-781, Sept. 2015. ilus
Article in English | LILACS | ID: lil-756404

ABSTRACT

The emergence of ganciclovir (GCV) resistance during the treatment of human cytomegalovirus (HCMV) infection is a serious clinical challenge, and is associated with high morbidity and mortality. In this case report, we describe the emergence of two consecutive mutations (A594V and L595W) related to GCV resistance in a patient with HCMV retinitis and long-term HIV progression after approximately 240 days of GCV use. Following the diagnosis of retinitis, the introduction of GCV did not result in viral load reduction. The detected mutations appeared late in the treatment, and we propose that other factors (high initial HCMV load, previous GCV exposure, low CD4+ cell count), in addition to the presence of resistance mutations, may have contributed to the treatment failure of HCMV infection in this patient.


Subject(s)
Humans , Female , Middle Aged , AIDS-Related Opportunistic Infections/genetics , Antiviral Agents/therapeutic use , Cytomegalovirus Retinitis/genetics , Drug Resistance, Viral/genetics , Ganciclovir/therapeutic use , Mutation , AIDS-Related Opportunistic Infections/drug therapy , AIDS-Related Opportunistic Infections/virology , Cytomegalovirus Retinitis/drug therapy , Disease Progression , DNA, Viral/genetics , Treatment Failure , Viral Load/drug effects
4.
Braz. j. med. biol. res ; 46(8): 676-680, ago. 2013. graf
Article in English | LILACS | ID: lil-684529

ABSTRACT

Multipotent mesenchymal stromal cells (MSCs) were first isolated from bone marrow and then from various adult tissues including placenta, cord blood, deciduous teeth, and amniotic fluid. MSCs are defined or characterized by their ability to adhere to plastic, to express specific surface antigens, and to differentiate into osteogenic, chondrogenic, adipogenic, and myogenic lineages. Although the molecular mechanisms that control MSC proliferation and differentiation are not well understood, the involvement of microRNAs has been reported. In the present study, we investigated the role of miR-125b during osteoblastic differentiation in humans. We found that miR-125b increased during osteoblastic differentiation, as well as Runx2 and ALPL genes. To study whether the gain or loss of miR-125b function influenced osteoblastic differentiation, we transfected MSCs with pre-miR-125b or anti-miR-125b and cultured the transfected cells in an osteoblastic differentiation medium. After transfection, no change was observed in osteoblastic differentiation, and Runx2, OPN, and ALPL gene expression were not changed. These results suggest that the gain or loss of miR-125b function does not influence levels of Runx2, OPN, and ALPL during osteoblastic differentiation.


Subject(s)
Female , Humans , Male , Alkaline Phosphatase/metabolism , Cell Differentiation/physiology , Core Binding Factor Alpha 1 Subunit/metabolism , MicroRNAs/metabolism , Osteoblasts/cytology , Osteopontin/metabolism , Alkaline Phosphatase/genetics , Antigens, Differentiation/isolation & purification , Bone Marrow Cells/cytology , Core Binding Factor Alpha 1 Subunit/genetics , Gene Expression/physiology , Leukocytes, Mononuclear/cytology , Mesenchymal Stem Cells/cytology , MicroRNAs/genetics , Osteoblasts/metabolism , Osteogenesis/physiology , Osteopontin/genetics , Primary Cell Culture , Reverse Transcriptase Polymerase Chain Reaction , Transfection
5.
Braz. j. med. biol. res ; 45(2): 104-112, Feb. 2012. ilus, tab
Article in English | LILACS | ID: lil-614579

ABSTRACT

Few studies have reported the molecular epidemiological characterization of HIV-1 in the Northern region of Brazil. The present study reports the molecular and epidemiological characterization of 31 HIV-1 isolates from blood donors from the State of Amazonas who donated blood between April 2006 and March 2007. Serum/plasma samples from all donors were screened for HIV antibodies by ELISA and the results confirmed by Western blot analysis. Genomic DNA was extracted from the buffy coat using the Super Quik-Gene-DNA Isolation kit. Nested PCR was performed on the env, gag, and pol regions of HIV-1 using the Gene Amp PCR System 9700. Sequencing reactions were performed using the inner PCR primers and the DYEnamic™ ET Dye Terminator Kit, and phylogenetic analysis was performed using the gag, pol, and env gene sequences. We collected samples from 31 blood donors who tested positive for HIV-1 in confirmatory experiments. The male:female ratio of blood donors was 3.4:1, and the mean age was 32.4 years (range: 19 to 61 years). Phylogenetic analysis showed that subtype B is the most prevalent among Northern Brazilian HIV-1-seropositive blood donors. One HIV-1 subtype C and one circulating recombinant form (CRF_BF) of HIV-1 were identified in the State of Amazonas. This is the first study showing the occurrence of a possible "homogenous" subtype C in this region of Brazil. This finding could contribute to a better characterization of the HIV-1 strains that circulate in the country.


Subject(s)
Adult , Female , Humans , Middle Aged , Young Adult , Blood Donors , HIV Infections/virology , HIV-1 , Base Sequence , Blotting, Western , Brazil/epidemiology , Enzyme-Linked Immunosorbent Assay , Genes, env/genetics , Genes, gag/genetics , Genes, pol/genetics , HIV Infections/epidemiology , HIV-1 , Molecular Sequence Data , Phylogeny , Polymerase Chain Reaction
6.
Braz. j. med. biol. res ; 40(1): 57-67, Jan. 2007. ilus, tab
Article in English | LILACS | ID: lil-439668

ABSTRACT

Bone marrow is a heterogeneous cell population which includes hematopoietic and mesenchymal progenitor cells. Dysregulated hematopoiesis occurs in chronic myelogenous leukemia (CML), being caused at least in part by abnormalities in the hematopoietic progenitors. However, the role of mesenchymal stem cells (MSCs) in CML has not been well characterized. The objectives of the present study were to observe the biological characteristics of MSCs from CML patients and to determine if MSCs originate in part from donors in CML patients after bone marrow transplantation (BMT). We analyzed MSCs from 5 untreated patients and from 3 CML patients after sex-mismatched allogeneic BMT. Flow cytometry analysis revealed the typical MSC phenotype and in vitro assays showed ability to differentiate into adipocytes and osteoblasts. Moreover, although some RT-PCR data were contradictory, combined fluorescence in situ hybridization analysis showed that MSCs from CML patients do not express the bcr-abl gene. Regarding MSCs of donor origin, although it is possible to detect Y target sequence by nested PCR, the low frequency (0.14 and 0.34 percent) of XY cells in 2 MSC CML patients by fluorescence in situ hybridization analysis suggests the presence of contaminant hematopoietic cells and the absence of host-derived MSCs in CML patients. Therefore, we conclude that MSCs from CML patients express the typical MSC phenotype, can differentiate into osteogenic and adipogenic lineages and do not express the bcr-abl gene. MSCs cannot be found in recipients 12 to 20 months after BMT. The influence of MSCs on the dysregulation of hematopoiesis in CML patients deserves further investigation.


Subject(s)
Humans , Male , Female , Adolescent , Adult , Middle Aged , Bone Marrow Transplantation , Fusion Proteins, bcr-abl/genetics , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/surgery , Mesenchymal Stem Cells , Transplantation Conditioning , Chimera , Fusion Proteins, bcr-abl/analysis , Hematopoiesis , In Situ Hybridization, Fluorescence , Mesenchymal Stem Cells , Phenotype , Reverse Transcriptase Polymerase Chain Reaction , Time Factors
7.
Rev. ciênc. farm. básica apl ; 26(2): 145-148, 2005. tab
Article in English | LILACS | ID: lil-428174

ABSTRACT

The aim of this research was to evaluate the susceptibility profile of Pseudomonas spp. and the prevalence of bacterial samples isolated from horizontal surfaces surrounding wash-basins used by dentists in several adjoined consulting-rooms, at points next to and at a distance from the basin, before and after surgical procedures. Our results showed a high percentage of Gram-positive cocci and Gram-negative bacilli; 34.66% were Staphylococcus spp. and 30.12% were non-fermentative Gram-negative bacilli among which Pseudomonas spp. (40.90%) was the commonest genus. Analysis of the susceptibility profile of Pseudomonas spp. isolates by determining the minimal inhibitory concentration (MIC) of 14 antibiotics showed a great variation among the strains and high rates of resistance to cefazolin, ceftazidime and aztreonan. Of the 14 antibiotics tested, 59.03% were found to be active against all the environmental isolates. Strains were resistant to aztreonan (62.82%), while susceptibility to third generation cephalosporins was variable


Subject(s)
Gram-Negative Bacteria , Gram-Negative Bacteria/isolation & purification , Gram-Positive Bacteria , Gram-Positive Bacteria/isolation & purification , Dental Offices , Pseudomonas Infections/epidemiology , Pseudomonas aeruginosa
SELECTION OF CITATIONS
SEARCH DETAIL